Arsenal Capital Partners related stories
All articles and analysis
Arsenal scores 4.1x on pharma exitThe New York-based firm has sold its portfolio company Scientific Protein Laboratories for about 4.1x to a publicly traded buyout firm, says a source close to the deal.
- Arsenal creates life science platform
The New York-based firm has combined two of its portfolio companies to create Vertellus Specialties.
- Arsenal acquires pharma distributor
The upstart New York middle-market firm has acquired Priority Air Express from Berwind Financial for $75 million, its third investment since closing a debut fund last June.
- Arsenal buys pharma co from Wyeth for $81m
The New York firm acquires Scientific Protein Laboratories, a maker of ingredients for end-use pharmaceuticals, in its fifth portfolio acquisition for its debut fund, closed last June.
- Americas
Americas 2003-10-01 Staff Writer America Monitor Secrets worth keeping? Regardless of what will eventually be decided by a Californian superior
- LGT backs US first time fund
The Swiss-based private equity group is among a group of international investors in Arsenal Capital Partners' debut $300m mid-market buyout fund.